Dermatol. praxi. 2007;1(4):157-159

Capillaroscopy by systemic connective tissue diseases

MUDr. Kateřina Libigerová, MUDr. Jaroslav Urbánek, MUDr. Martin Tichý Ph.D, MUC. Jan Šternberský
Klinika chorob kožních a pohlavních LF UP a FN Olomouc

Systemic connective tissue diseases (SCTD) include the group of disorders of autoimunne etiology. Their unifying features are quantitative and qualitative changes of collagen and elastic tissue and fibroblast. SCTD also typically affect the adnexal structures, nerves and vessels. The occurence of SCTD is higher than 3 % in the population. Ranynaud´s phenomenon is often the first sympton of SCTD. Capillaroscopy is a non invasive diagnostic method, which can differentiate primary Raynaud´s disease from secondary Raynaud´s phnomenon and that is why the examination play important role in diagnostics of early stages of SCTD. The significant capillaroscopical changes are characterized.

Keywords: systemic connective tissue diseases, Raynaud´s phenomenon, Raynaud´s disease, Raynaud´s syndrome

Published: February 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Libigerová K, Urbánek J, Tichý M, Šternberský J. Capillaroscopy by systemic connective tissue diseases. Dermatol. praxi. 2007;1(4):157-159.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Colwell JA, Halusshka PV, Sarji KE et al. Vascular disease in diabetes. Pathophysiological machanisms and therapy. Arch Intern Med 1979; 139: 225-230. Go to original source...
    2. Cortes S, Cutolo M. Capillaroscopic patterns in rheumatic diseases. Acta Reumatol. 2007 JanMar; 32 (1): 29-36.
    3. Cutolo M, Pizzorni C, Sulli A. Nailfold video-capillaroscopy in systemic sclerosis. Z Rheumatol. 2004 Dec+; 63 (6): 457-62. Go to original source... Go to PubMed...
    4. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 155-160. Go to PubMed...
    5. Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology (Oxford). 2006 Oct; 45 Supl 4: iv43-iv46. Go to original source... Go to PubMed...
    6. Dobrev H. In vivo study of skin mechanical properties in Raynaud´s phenomenon. Skin Res Technol. 2007 Feb; 13 (1): 91-94. Go to original source... Go to PubMed...
    7. Gayraud M. Raynaud´s phenomenon. Joint Bone Spine. 2007 Jan; 74 (1): e1-8. Epub 2006 Dec 4. Go to original source... Go to PubMed...
    8. Houtman PM, Kallenberg CGM, Fidler V, Wouda AA. Diagnostic significance of nailfold capilary patterns in patients with RP: analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 1986; 13: 556-563. Go to PubMed...
    9. Chen ZY, Silver RM, Ainsworth SK et al. Association between fluorescent antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 1984; 77: 812-822. Go to original source... Go to PubMed...
    10. Jayson MIV. The microcirculation in systemic sclerosis. Clin Exp Rheumatol 1984; 2: 85-91. Go to PubMed...
    11. Klener P. Vnitřní lékařství. Funkční cévní poruchy - vazoneurózy. Raynaudův fenomén. Praha: Galén 1999. 242-243.
    12. Maricq HR. Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981; 24: 1159-1165. Go to original source... Go to PubMed...
    13. Maricq HR, Harpe FE, Khan MM et al. Microvascular abnormalities as possible predictors of disease subset in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983; 1: 195-205. Go to PubMed...
    14. Riedl L. Tožičkova sbírka lékařských příruček. Kapilaroskopie 1936; 10-11.
    15. Sprynger M. Raynaud´s phenomenon. Rev Med Liege. 2004 Jun; 59 (6): 378-84. Go to PubMed...
    16. Štork J. Sklerodermie. Praha: Galén 1996. 51-56.
    17. Zeni S, Ingegnoli F. Raynaud´s phenomenon. Reumatismo. 2004 Apr-Jun; 56 (2): 77-81. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.